Trials / Completed
CompletedNCT05119777
HArmonyCa Injectable Gel for Mid Face Soft Tissue Augmentation
Prospective, Open Label, Post Marketing Study of the Safety and Effectiveness of HArmonyCa Injectable Gel for Mid-face Soft Tissue Augmentation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, open label, post marketing study of the safety and effectiveness of HArmonyCa injectable gel for mid-face soft tissue augmentation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HArmonyCa Injectable Gel | Subdermal or deep dermal injection |
Timeline
- Start date
- 2021-10-13
- Primary completion
- 2023-09-15
- Completion
- 2023-09-15
- First posted
- 2021-11-15
- Last updated
- 2024-09-19
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05119777. Inclusion in this directory is not an endorsement.